We remain very concerned that the CMS proposal could harm Medicare beneficiaries who have cancer by triggering major cuts to physician reimbursement, especially for Part B drugs and for drugs that have been newly introduced to the market.
Clifford HudisHave a look at (or listen to our podcast) @ASCO 's take on this year's proposed CMS fee schedule. Lots to consider here: bit.ly/2QhbrCV #ASCOconnection #ASCOinAction
In a new ASCO in Action Podcast, Edward Balaban, DO, FACP, FASCO, and ASCO delegate to the American Medical Association (AMA) House of Delegates (HOD); and Kristina Novick, MD, and ASCO alternate delegate to the AMA HOD join ASCO CEO Dr. Clifford A....
New Collaboration with Siddhartha Mukherjee, M.D.
Three-Hour Documentary to Premiere Spring 2020 on PBS
– Barak Goodman to Produce Major Series
Inspired by Mukherjee’s Award-Winning Book –
– WETA Washington, D.C., Will Convene Partners to...
Get easy-to-use tools to help you plan and manage care – from diagnosis through treatment and beyond – provided by Cancer.Net, including the latest oncologist-approved cancer information. Brought to you by the American Society of Clinical Oncology...